Diagnostics Is Becoming a Distributed-Sampling Infrastructure Business
One of the more revealing healthcare developments of the last forty-eight hours did not come from a trial readout or…
Author: Marcus Chen
Based in Singapore, Marcus Chen specializes in the rapidly evolving fields of genomics, CRISPR technologies, and personalized diagnostics. With a background in bioinformatics and science journalism, he explores how genetic insights are transforming patient care and reshaping the diagnostic landscape. His investigative pieces often highlight the intersection of big data, AI, and next-generation sequencing in modern medicine.
MEDIPOST Advances Regenerative Orthopedics with Phase III Trial for Knee Osteoarthritis
The landscape of regenerative medicine reached a significant milestone this week as MEDIPOST Inc. announced the treatment of the first U.S.…
The Decentralized Intelligence Layer: How BioLayer Is Rewiring the Biotech Ecosystem
The global biotech ecosystem is currently living through a critical data paradox. Researchers have unprecedented access to high-resolution biological information…
Clinical-Trial Outsourcing Is Becoming a Biosecurity Diligence Problem
For years, the biopharma industry treated global clinical-trial geography as an execution question. Companies went where patient recruitment was faster,…
Oncology Is Turning Maintenance Therapy Into Strategy
Drug development stories are often told through breakthroughs at the moment of diagnosis: a new target, a sharper biomarker, a…
Regulatory Speed Is Becoming Its Own Biotech Asset Class
The renewed fight over the FDA’s priority-voucher pathway suggests that review time is turning from an administrative variable into a…
Beyond the Scale: What GLP-1 Drugs Are Really Doing to Your Body
Ozempic and Wegovy have become household names for weight loss, but a wave of new research reveals they are reshaping…
From Simulation to Clinic: How AI Is Rewriting the Rules of Drug Discovery
A 10,000-fold acceleration in molecular simulation, a hidden cancer-protein pocket missed by leading AI tools, and the first human trials…
The Immune Reset: CAR T-Cell Therapy Offers a Potential Cure for Severe Lupus
A pioneering NHS trial successfully utilizes genetically modified T-cells to drive severe, treatment-resistant lupus into remission, signaling a paradigm shift…
The Fiber Buffer: Rethinking Diet and Metabolic Health Through the Microbiome
New research highlights how specific dietary fibers and prebiotics can stabilize glucose, combat fatty liver, and outperform extreme dietary restrictions.…
Pharma’s $106 Billion Summer: The Bolt-On Strategy to Beat the Patent Cliff
How a surge in targeted mid-sized acquisitions is reshaping oncology and metabolic pipelines as major drugmakers brace for a revenue…